DENTALFLUORO

Carotid Artery Plaque

Hospices Civils de LyonSmall moleculeN/ADormant

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 95/ 100

Competitive context

1 Active assets in the Carotid Artery Plaque cohort.

Asset / Sponsor	Phase	Rating
Iodixanol Enrico Ammirati	Phase 3	B
Sonovue Enrico Ammirati	Phase 3	B
[18F]AlF-OC Universitaire Ziekenhuizen KU Leuven	Phase 2	CCC
Herbal Medicine C-117 Guangzhou University of Traditional Chinese Medicine	Phase 2	CCC
Rimonabant Sanofi	Phase 3	CC

Same molecule, other indications

DENTALFLUORO is also rated in:

metastatic carcinoma in the boneDormant

BB

Indicative ·

66 / 100

Bone Metastases From Breast or Prostate CancerDormant

B

Indicative ·

63 / 100

prostate neoplasmDormant

B

Indicative ·

57 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.